Harvard Pilgrim Health Care Home
  HPHConnect
 
  Learn more.
  Sign up for HPHConnect.
Medical Management
E-Transactions
HPHConnect
Pharmacy
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Newsroom
Office Support
Products
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
 
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

August 2013

P&T Committee Updates 


At a June 3, 2013 meeting, the Harvard Pilgrim’s Pharmacy & Therapeutics Committee reviewed several medications and decided the following.

P&T Committee Review and Decisions

Name

Indication

Decision

Vascepa
(icosapent ethyl)
Vascepa is used to lower triglyceride levels in adults. It should be reserved for people with very high levels of triglycerides (>500mg/dL). Continued coverage at  Tier 3
(Tier 4 for 4-Tier formulary)
Myrbetriq
(mirabegron)
Myrbetriq is used to treat overactive bladder. Continued coverage at  Tier 3
(Tier 4 for 4-Tier formulary)
Nesina
(alogliptin) 
Nesina, part of a class of oral drugs known as DPP-4 inhibitors, is used to improve glycemic control in adults with type 2 diabetes. Continued covered at  Tier 3
(Tier 4 for 4-Tier formulary)

 

Email this article to a colleague   

Receive Network Matters by e-mail

Network Matters Archives

Download printer-friendly version

HPHCURRENT EVENTS

Cardiac Medication Adherence Report Now Available

Reminder: Maintain Up-To-Date Panel Status Information

CLINICIAN CORNER

Intralesional Injection Procedures: No Prior Authorization Required

Medical Criteria for Electric and Myoelectric Prosthetics

TMS Now Covered with Prior Authorization

Continuous Glucose Monitoring Systems

New Prior Authorization Requirement for Six Medications

Gastric Emptying Payment Policy Update

P&T Committee Updates

Specialty Pharmacy Updates

Recognizing Postpartum Depression in the Primary Care Setting

OFFICE ASSISTANT

Changes to HPHConnect New User Accounts

Qualitative Drug Screen Testing

PUBLICATION INFORMATION

Eric H. Schultz,
President and Chief Executive Officer

Richard Weisblatt PhD,
Senior Vice President, Provider Network

Annmarie Dadoly,
Editor

Kristin Edmonston,
Production Coordinator